Jump to Main Contents
ncc en
HOME > Publication & Reports > Annual Report 2020 > Center for Cancer Genomics and Advanced Therapeutics

Annual Report 2020

Section of Liaison for Cancer Genomic Medicine Hospitals

Tatsuya Suzuki, Natsuko Okita, Hideki Ueno, Yusuke Okuma

Introduction

 Our mission in this liaison room is to promote the cancer genomic medicine by sharing and solving practical problems of the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) among the staff at Cancer Genomic Medicine Hospitals.

 Cancer genomic medicine requires enrichment of human resources, systems, know-how in operations, and the realization of different needs of each region. Our aim is to capture and share these needs, issues, or practical know-how, so that cancer genomic medicine is performed in a cooperative and efficient manner, and at the same time ensure safety for patients.

 We periodicity hold online meetings with members of the designated core hospitals for Cancer Genomics Medicine nationwide to share issues and discuss solutions.

The Team and What We Do

 Our team monitors advanced therapeutics in relation to cancer gene panel tests, serves as secretariat to the clinical working group of the General Assembly of the Designated Core Hospitals for Cancer Genomic Medicine, and promotes collaboration with Designated Core Hospitals for Cancer Genomic Medicine.